AXGN · Axogen Inc
United States · RS rating 95 · As of 2026-11-03
| Price | 49.50 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 97 / 81 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 61 / 58 / 39 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -35.7% |
| Sales growth Q/Q | -0.3% |
| Distance from 52-week high | +4.3% |
| Market cap (USD) | $1.9B |